Bo Ban

1.5k total citations
66 papers, 868 citations indexed

About

Bo Ban is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Bo Ban has authored 66 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Cardiology and Cardiovascular Medicine and 13 papers in Molecular Biology. Recurrent topics in Bo Ban's work include Growth Hormone and Insulin-like Growth Factors (19 papers), Lipid metabolism and disorders (16 papers) and Liver Disease Diagnosis and Treatment (7 papers). Bo Ban is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (19 papers), Lipid metabolism and disorders (16 papers) and Liver Disease Diagnosis and Treatment (7 papers). Bo Ban collaborates with scholars based in China, Taiwan and United States. Bo Ban's co-authors include Yanjie Yang, Zhengxue Qiao, Xiaohui Qiu, Xiuxian Yang, Jiawei Zhou, Mei Zhang, Hui Pan, Jing Chen, Bee K. Tan and Bo Bai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Gene.

In The Last Decade

Bo Ban

63 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Ban China 15 178 170 152 142 137 66 868
Charles Tzu‐Chi Lee Taiwan 22 175 1.0× 283 1.7× 193 1.3× 73 0.5× 125 0.9× 63 1.4k
Cornelia Enzenbach Germany 14 155 0.9× 152 0.9× 146 1.0× 153 1.1× 101 0.7× 24 1.1k
Mrudula Utukuri United Kingdom 7 283 1.6× 193 1.1× 160 1.1× 140 1.0× 53 0.4× 7 863
Xiaojie Feng China 16 122 0.7× 232 1.4× 124 0.8× 130 0.9× 140 1.0× 41 1.4k
Zhao Hu China 16 118 0.7× 171 1.0× 77 0.5× 145 1.0× 110 0.8× 52 986
Lana Dixon United Kingdom 16 160 0.9× 172 1.0× 165 1.1× 111 0.8× 113 0.8× 46 1.1k
Bei Li China 16 158 0.9× 90 0.5× 146 1.0× 175 1.2× 57 0.4× 51 974
Jennifer L. Young United States 14 316 1.8× 159 0.9× 85 0.6× 125 0.9× 109 0.8× 50 1.2k
Sandra J. Hamilton Australia 19 195 1.1× 121 0.7× 100 0.7× 167 1.2× 190 1.4× 38 1.2k
Mark Kelson United Kingdom 18 144 0.8× 101 0.6× 86 0.6× 228 1.6× 110 0.8× 54 1.1k

Countries citing papers authored by Bo Ban

Since Specialization
Citations

This map shows the geographic impact of Bo Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ban more than expected).

Fields of papers citing papers by Bo Ban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ban. The network helps show where Bo Ban may publish in the future.

Co-authorship network of co-authors of Bo Ban

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ban. A scholar is included among the top collaborators of Bo Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ban. Bo Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Baolan, et al.. (2025). Association between SPISE and NAFLD in patients with type 2 diabetes. Frontiers in Medicine. 12. 1454938–1454938. 1 indexed citations
2.
Ji, Baolan, et al.. (2025). Association Between a New Model of Insulin Sensitivity and Hypertension in Patients With Type 2 Diabetes: A Cross‐Sectional Study. Journal of Clinical Hypertension. 27(2). e70008–e70008.
3.
Wang, Xin, et al.. (2025). Association between FT4/FT3 ratio and microalbuminuria in euthyroid patients with type 2 diabetes mellitus. Scientific Reports. 15(1). 7324–7324. 1 indexed citations
4.
Wang, Yutong, Yiling He, Hongbo Yang, et al.. (2025). Exercise-induced metabolomics and its association with metabolic health in adolescents. Nutrition & Metabolism. 22(1). 48–48. 1 indexed citations
5.
Ji, Baolan, et al.. (2024). METS-IR, a Novel Simple Insulin Resistance Index, is Associated with NAFLD in Patients with Type 2 Diabetes Mellitus. Diabetes Metabolic Syndrome and Obesity. Volume 17. 3481–3490. 9 indexed citations
6.
Jiao, Jing, Y. Wang, Chen Zhu, et al.. (2024). Ultrasound based radiomics model for assessment of placental function in pregnancies with preeclampsia. Scientific Reports. 14(1). 21123–21123. 1 indexed citations
7.
Zhao, Qianqian, Yanying Li, Chuan-Peng Zhang, et al.. (2023). Clinical and genetic evaluation of children with short stature of unknown origin. BMC Medical Genomics. 16(1). 194–194. 4 indexed citations
8.
Zhao, Qianqian, et al.. (2023). Non-linear relationship between sleep duration and blood pressure in children with short stature. Frontiers in Pediatrics. 11. 1302750–1302750. 2 indexed citations
9.
Yang, Qing, Yanying Li, Yanhong Zhang, et al.. (2022). Association Between the Growth Hormone/Insulin-Like Growth Factor-1 Axis and Muscle Density in Children and Adolescents of Short Stature. Frontiers in Endocrinology. 13. 920200–920200. 1 indexed citations
10.
Liu, Fupeng, Bo Ban, Guangxin Li, et al.. (2022). Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus. Frontiers in Nutrition. 9. 1035853–1035853. 4 indexed citations
11.
Zhao, Qianqian, et al.. (2021). A Retrospective Analysis of Patients with Short Stature in Eastern China between 2013 and 2019. BioMed Research International. 2021(1). 132–134. 6 indexed citations
12.
Zhao, Qianqian, et al.. (2021). Association between triglyceride glucose index and peak growth hormone in children with short stature. Scientific Reports. 11(1). 1969–1969. 5 indexed citations
13.
Kou, Shuang, Mei Zhang, Baolan Ji, et al.. (2020). Association between systolic blood pressure and uric acid in Chinese children and adolescents with idiopathic short stature: a cross-sectional study. Journal of Human Hypertension. 35(5). 472–478. 2 indexed citations
14.
Li, Dan, et al.. (2020). Association between bilirubin levels and diabetic retinopathy in type 2 diabetes mellitus. Zhonghua neifenmi daixie zazhi. 36(3). 227–234. 1 indexed citations
15.
Zhao, Qianqian, Mei Zhang, Baolan Ji, et al.. (2020). Relationship between hemoglobin and insulin-like growth factor-1 in children and adolescents with idiopathic short stature. BMC Endocrine Disorders. 20(1). 119–119. 6 indexed citations
17.
Liu, Sisi, Bo Ban, Hui Pan, et al.. (2017). The research of prevalence of short stature of children and adolescents aged from 6 to 16 years in Jining. 5(3). 188–191. 3 indexed citations
18.
Ban, Bo, et al.. (2014). Etiologic and diagnostic analysis of 270 children with short stature in China Jining region. 2(2). 100–104. 1 indexed citations
19.
Liang, Kai, Chuanlong Wu, Huiran Zhang, et al.. (2014). Efficacy and safety of Tianmaixiaoke tablet combined with metformin in patients with newly diagnosed type 2 diabetes mellitus. 6(9). 650–654. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026